Tag
donanemab
-
Reporters uncover conflicts and dubious data on latest Alzheimer’s drug
A blockbuster story in The BMJ showed major concerns surrounding the approval process, efficacy and safety of the Alzheimer’s drug…
-
Medicare announces coverage of costly Alzheimer’s medication. That could mean high premiums for beneficiaries
Medicare coverage of new Alzheimer’s treatments will raise premiums and increase out-of-pocket costs for beneficiaries, new analysis finds.